Yes, diclofenac is appropriate for hip osteoarthritis
Diclofenac is an effective NSAID for hip osteoarthritis and should be added or substituted when acetaminophen provides inadequate pain relief. 1
Treatment Algorithm for Hip Osteoarthritis
First-Line Approach
Start with acetaminophen up to 4,000 mg/day (though evidence shows it has very small effect sizes and may be ineffective for most patients) 2, 3. However, given acetaminophen's limited efficacy, many patients will require escalation to NSAIDs.
When to Use Diclofenac
Add or substitute diclofenac when:
- Acetaminophen fails to provide adequate pain relief
- Patient has inflammatory signs (effusion, warmth)
- Pain significantly impacts function
Diclofenac demonstrates superior efficacy compared to opioid combinations (effect size = -0.18,95% CI -0.33 to -0.04) 1 and provides clinically meaningful pain relief with a number needed to treat of 4 1.
Dosing and Formulation
Oral diclofenac: 100-150 mg/day in divided doses (50 mg 2-3 times daily) 4
- Diclofenac 150 mg/day has ≥99% probability of exceeding minimal clinically relevant pain reduction 5
- Use the lowest effective dose for the shortest duration 4
Topical diclofenac: Consider as first-line for knee OA (70-81 mg/day), though evidence is limited for hip OA given joint depth 6
Critical Safety Considerations
Gastrointestinal Protection (MANDATORY)
Diclofenac carries dose-dependent GI bleeding risk:
- 75 mg/day: OR = 2.2 (95% CI 0.8-5.8)
- 75-150 mg/day: OR = 3.2 (95% CI 1.9-5.5)
150 mg/day: OR = 12.2 (95% CI 5.6-26.7) 1
You must co-prescribe gastroprotection:
- Proton pump inhibitor (PPI) - preferred strategy 7
- Alternative: COX-2 selective inhibitor + PPI for highest GI risk patients 7
- Avoid misoprostol due to diarrhea (RR = 1.81) 1
Specific Contraindications and Precautions
Do NOT use diclofenac if:
- Chronic kidney disease stage IV-V (eGFR <30 cc/min) 7
- Active GI bleeding
- History of GI bleed within past year (if NSAID needed, use COX-2 inhibitor + PPI) 7
Use with extreme caution if:
- Age ≥75 years (strongly prefer topical over oral NSAIDs) 7
- CKD stage III (eGFR 30-59 cc/min) - individualize based on risk/benefit 7
- Taking low-dose aspirin for cardioprotection (avoid ibuprofen due to interaction; diclofenac acceptable with PPI) 7
- Advanced liver disease or coagulopathy 4
Hepatotoxicity Monitoring
Monitor transaminases:
- Baseline measurement before starting
- Repeat at 4-8 weeks after initiation 4
- Meaningful elevations (>3x ULN) occur in ~4% of patients 4
- Discontinue immediately if transaminases persist elevated, worsen, or if systemic symptoms develop (nausea, fatigue, jaundice, right upper quadrant pain) 4
Common Pitfalls to Avoid
Using NSAIDs without gastroprotection - This is the most common error. Always co-prescribe a PPI 7
Prescribing to elderly without considering topical alternatives - For patients ≥75 years, topical NSAIDs are strongly preferred when feasible 7
Combining with aspirin without PPI - If patient takes low-dose aspirin, the PPI is non-negotiable 7
Failing to monitor liver function - Check transaminases at 4-8 weeks, as severe hepatotoxicity can occur without warning 4
Using doses >150 mg/day - Risk increases dramatically without proportional benefit 1
Alternative if Diclofenac Fails or Contraindicated
- Intra-articular corticosteroid injection (with ultrasound guidance for hip) 2, 3
- Duloxetine (centrally acting agent) 2, 3
- Tramadol (conditional recommendation only; inferior to NSAIDs with more side effects) 1, 2
- Avoid opioids beyond tramadol - they cause more side effects (RR = 7.25) without superior efficacy 1
The evidence strongly supports diclofenac as an effective treatment for hip osteoarthritis when used at appropriate doses with mandatory gastroprotection, particularly in patients who have failed acetaminophen.